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Letter to the Editor
The eighth alternative to evidence based medicine in the early era of the COVID-19 pandemic: Too
much emergency and emotion, too little evidence
“Clinical decisions should, as far as possible, be evidence based. So runs
the current clinical dogma. We are urged to lump all the relevant randomised
controlled trials into one giant meta-analysis and come out with a combined
odds ratio for all decisions. Physicians, surgeons, nurses are doing it; soon
even the lawyers will be using evidence based practice. But what if there is no
evidence on which to base a clinical decision?”. That was the incipit of a
curious and ironic article by David Isaacs and Dominic Fitzgerald issued
more than 20 years ago by the British Medical Journal [1]
In their satiric observation, the authors described seven alternatives
to Evidence Based Medicine (EBM) (Table) when no evidence is available
to confront a clinical question or situation. EBM was promoted at
McMaster University (Ontario, Canada) as a programme for medical
students in 1990 by Gordon Guyatt, the lead author of a landmark ar-
ticle in JAMA, two years later, subsequently cited more than 4500 times
[2].
EBM determined a philosophical and intellectual revolution in the
practice of modern medicine; while imperfect and with limitations, it
has permitted the transition from empiricism to the practice of medi-
cine based on evidence obtained by a rigorous and scientifically or-
iented method. EBM has been criticized, misunderstood and misused
over the years, even though its role and its rules remained evident to
those who trusted and appreciated it [3]. In 2014, 22 years after the
publication of its JAMA manifesto, Trisha Greenhalgh and others
moved a substantial critique to EBM, emphasizing - along with many
benefits – the unintended negative consequences and the need for new
directions for EBM [4]. The authors reaffirmed the original role of EBM,
i.e. refocusing actionable and robust evidence in the appropriate con-
text and with the professional expertise required to optimize individual
patient care. They named this process the Reinassance of EBM.
In late December 2019, an outbreak of coronavirus disease 2019
(COVID-19) caused by severe acute respiratory syndrome coronavirus 2
(SARS‑CoV‑2) was identified in Wuhan, China [5]. The outbreak ra-
pidly spread across continents becoming the ongoing pandemic which
had caused more than 2.95 million confirmed infections and 205,000
deaths in 185 countries as of April 26th 2020 [6]. The rapidly evolving
COVID-19 pandemic determined in less than four months tragic and
disruptive consequences, both for individuals and health care systems,
in the absence of treatments objectively tested for efficacy. The use of
drugs against COVID-19 relied largely on anecdotal reports and un-
derpowered studies with major methodological bias and limitations.
The partner in crime was of course the rapidity of viral spread along
with the dramatic burden of morbidity and mortality in the general
population. In the last three months, the medical literature has been
flooded with articles of dubious robustness and undoubtable metho-
dological weakness, some of which found hospitality in distinguished
peer-reviewed medical journals. In normal times most of these articles
would have been likely rejected outright.
For many of us who “grew up” during the affirmation of EBM,
learning from its virtues and vices, the early era of COVID-19 pandemic
represented the denial of more than 20 years of its history. After the EBM
revolution, the present trend has taken the form of a counterrevolution
with unacceptable consequences. Those who care for COVID-19 patients
have felt on their skin a sense of skepticism turning to defeat and im-
potence while treating patients with drugs that seemed more toxic than
effective [7], based on inconsistent reports contradicting each other in a
matter of weeks [8,9]. Unfortunately, the aphorism by Sir William Osler
“We administer drugs we don't know in a body that we know even less” never
sounded so true! [10]. All that proved to be too much Emergency- and
Emotion-Based and too little Evidence Based Medicine.
Many methodologically sound clinical trials are ongoing in order to
answer the unmet clinical needs for COVID-19 treatment, duly regis-
tered at ClinicalTrials.gov. We are anxiously awaiting those results to
fill current gaps in knowledge and improve the delivery of appropriate
care to our patients affected by COVID-19. Meanwhile, we must rely on
the best of our knowledge, clinical experience and judgement, with a
healthy dose of skepticism towards a flourish of “experts” in a disease
that was totally unknown only four months ago.
Isaacs and Fitzgerald concluded their report with the comment that
there “are plenty of alternatives for the practicing physician in the absence
of evidence and this is what makes medicine an art as well as a science” [1].
If Emotionality and Emergency should be the eighth alternative to
Evidence (Table), we will continue to prefer and promote the original
EBM with no alternatives at all, practicing medicine as a science and an
art of judicious balance between knowledge and clinical judgement in
making decisions about the care of individual patients.
Table 1.
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Table 1
xxx
Basis for clinical decisions Marker Measuring device Unit of measurement
Evidence Randomised controlled trial Meta-analysis Odds ratio
Eminence* Radiance of white air Luminometer Optical density
Vehemence* Level of stridency Audiometer Decibels
Eloquence* Smoothness of tongue Teflometer Adhesin score
Providence* Level of religious fervor Sextant to measure angle of
genuflection
International units of piety
Diffidence* Level of gloom Nihilometer Sighs
Nervousness* Litigation phobia level Every conceivable test Bank balance
Confidence* Bravado Sweat test No sweat
Emergency and Emotional Emergency needing of evidence, and wavering of available
information
Oscillometer Degrees of deviation from ultimate
evidence
* Seven alternatives to evidence based medicine originally described in the article by Isaacs and Fitzgerald [1]
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